Johnson & Johnson engages in the research and development, manufacture, and sale of various products in the health care field worldwide. Its Consumer segment provides products used in baby care, skin care, oral care, wound care, and women’s health care fields, as well as nutritional and over-the-counter pharmaceutical products under AVEENO, BAND-AID, CAREFREE, CLEAN & CLEAR, JOHNSON’S, LISTERINE, MOTRIN IB, NEUTROGENA, RoC, PEPCID AC, REMBRANDT, SPLENDA, STAYFREE, SUDAFED, TYLENOL, and Vendôme brands. The company’s Pharmaceutical segment offers products in various therapeutic areas, such as anti-infective, antipsychotic, cardiovascular, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, urology, and virology. It offers RISPERDAL to treat the symptoms of schizophrenia, bipolar mania, and irritability associated with autistic behavior in indicated patients; RISPERDAL CONSTA, an injectable, and INVEGA Extended-Release tablets, for treating schizophrenia; REMICADE, a biologic for treating Crohn’s disease, ankylosing spondylitis, psoriasis, psoriatic arthritis, ulcerative colitis, and used in the treatment of rheumatoid arthritis; PROCRIT that stimulates red blood cell production; TOPAMAX for adjunctive and monotherapy use in epilepsy, as well as for the treatment of migranes; LEVAQUIN and FLOXIN anti-infective products; and ACIPHEX/PARIET, a proton pump inhibitor. This segment also provides DURAGESIC to treat chronic pain; CONCERTA for treating attention deficit hyperactivity disorder; and ORTHO EVRA, a contraceptive patch. Johnson & Johnson’s Medical Devices and Diagnostics segment offers circulatory disease management, orthopaedic joint reconstruction and spinal care, wound care and women’s health, minimally invasive surgical, blood glucose monitoring and insulin delivery, and diagnostic products, as well as disposable contact lenses. The company was founded in 1885 and is based in New Brunswick, New Jersey.